NANOVIRICIDES, INC. Unrecognized Tax Benefits, Interest on Income Taxes Expense
NANOVIRICIDES, INC. (NNVC) reported Unrecognized Tax Benefits, Interest on Income Taxes Expense of $0 for the 12-month period ending 2023-06-30, per its 10-K filed 2023-10-13.
Discontinued › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense · last filed 2023-10-13
- NANOVIRICIDES, INC. unrecognized tax benefits, interest on income taxes expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- NANOVIRICIDES, INC. unrecognized tax benefits, interest on income taxes expense for fiscal 2022 was $1.26K.
- NANOVIRICIDES, INC. unrecognized tax benefits, interest on income taxes expense for fiscal 2021 was $0.00.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Expense 12 month |
|---|---|
| 2023-06-30 | $0.00 10-K · filed 2023-10-13 |
| 2022-06-30 | $1.26K 10-K · filed 2023-10-13 |
| 2021-06-30 | $0.00 10-K · filed 2022-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |